iRhythm Technologies, Inc.
US ˙ NasdaqGS ˙ US4500561067

Introduction

This page provides a comprehensive analysis of the known insider trading history of Kevin C Oboyle. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Kevin C Oboyle has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
Director 17,333
US:IRTC / iRhythm Technologies, Inc. Director 2,035
US:OM / Outset Medical, Inc. Director 24,118
US:NVRO / Nevro Corp. Director 0
US:SIEN / Sientra, Inc. Director 220,978
Director 0
US:98235TAA5 / Wright Medical Group N.V. Bond Director 0
US:ZLTQ / ZELTIQ Aesthetics, Inc. Director 0
US:DRTX / Durata Therapeutics Inc Director 0
US:NUVA / Nuvasive Inc CFO and Executive VP 110,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Kevin C Oboyle. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases IRTC / iRhythm Technologies, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in IRTC / iRhythm Technologies, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IRTC / iRhythm Technologies, Inc. Insider Trades
Insider Sales IRTC / iRhythm Technologies, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in IRTC / iRhythm Technologies, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IRTC / iRhythm Technologies, Inc. Insider Trades
Insider Purchases OM / Outset Medical, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in IRTC / iRhythm Technologies, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OM / Outset Medical, Inc. Insider Trades
Insider Sales OM / Outset Medical, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in IRTC / iRhythm Technologies, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OM / Outset Medical, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Kevin C Oboyle as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-07-24 2025-07-22 4 CARL CARLSMED, INC.
Common Stock
A - Award 17,333 17,333
2025-07-08 2025-07-07 4 IRTC iRhythm Technologies, Inc.
Common Stock
A - Award 2,035 2,035
2025-06-04 2025-06-02 4 OM Outset Medical, Inc.
Common Stock
A - Award 8,983 24,118 59.35
2025-05-14 2025-05-14 4 OM Outset Medical, Inc.
Common Stock
A - Award 15,135 15,135
2025-04-03 2025-04-03 4 NVRO NEVRO CORP
Common Stock
D - Sale to Issuer -43,396 0 -100.00
2024-05-28 2024-05-23 4 NVRO NEVRO CORP
Common Stock
A - Award 19,169 43,396 79.12
2023-05-30 2023-05-25 4 NVRO NEVRO CORP
Common Stock
A - Award 6,754 24,227 38.65
2022-06-13 2022-06-09 4 SIEN Sientra, Inc.
Common Stock
A - Award 103,306 220,978 87.79
2022-05-27 2022-05-26 4 NVRO NEVRO CORP
Common Stock
A - Award 4,155 17,473 31.20
2021-12-16 2021-12-14 4 NVRO NEVRO CORP
Common Stock
P - Purchase 1,400 13,318 11.75 83.80 117,320 1,116,048
2021-12-16 2021-12-14 4 NVRO NEVRO CORP
Common Stock
P - Purchase 1,000 11,918 9.16 83.75 83,750 998,132
2021-06-15 2021-06-10 4 SIEN Sientra, Inc.
Common Stock
A - Award 16,870 117,672 16.74
2021-05-26 2021-05-25 4 NVRO NEVRO CORP
Common Stock
A - Award 1,167 10,918 11.97
2021-04-22 2021-04-22 4 GNMK GenMark Diagnostics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -13,426 0 -100.00
2021-04-22 2021-04-22 4 GNMK GenMark Diagnostics, Inc.
Common Stock
U - Other -131,678 0 -100.00 24.05 -3,166,856
2021-02-19 2021-02-18 4 GNMK GenMark Diagnostics, Inc.
Common Stock
A - Award 10,130 131,678 8.33
2020-11-13 2020-11-11 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
D - Sale to Issuer -7,800 0 -100.00
2020-11-13 2020-11-11 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
D - Sale to Issuer -6,448 0 -100.00
2020-11-13 2020-11-11 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
D - Sale to Issuer -7,538 0 -100.00
2020-11-13 2020-11-11 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
D - Sale to Issuer -6,034 0 -100.00
2020-11-13 2020-11-11 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
D - Sale to Issuer -11,018 0 -100.00
2020-11-13 2020-11-11 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
D - Sale to Issuer -11,765 0 -100.00
2020-11-13 2020-11-11 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
D - Sale to Issuer -10,275 0 -100.00
2020-11-13 2020-11-11 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
D - Sale to Issuer -9,907 0 -100.00
2020-11-13 2020-11-11 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
D - Sale to Issuer -11,691 0 -100.00
2020-11-13 2020-11-11 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
U - Other -16,306 0 -100.00 30.75 -501,410
2020-06-09 2020-06-05 4 SIEN Sientra, Inc.
Common Stock (RSUs)
A - Award 27,717 100,802 37.92
2020-06-02 2020-05-29 4 GNMK GenMark Diagnostics, Inc.
Common Stock
A - Award 17,998 121,548 17.38
2020-05-26 2020-05-21 4 NVRO NEVRO CORP
Common Stock
A - Award 1,376 9,751 16.43
2020-03-09 2020-03-06 4 GNMK GenMark Diagnostics, Inc.
Common Stock
P - Purchase 10,800 103,550 11.64 4.53 48,924 469,082
2020-02-27 2020-02-25 4 GNMK GenMark Diagnostics, Inc.
Common Stock
A - Award 3,973 92,750 4.48
2019-08-19 2019-08-16 4 GNMK GenMark Diagnostics, Inc.
Common Stock
S - Sale X -16,150 85,962 -15.82 6.51 -105,136 559,613
2019-08-19 2019-08-15 4 GNMK GenMark Diagnostics, Inc.
Stock Option (Right to Buy)
M - Exercise -18,050 0 -100.00
2019-08-19 2019-08-15 4 GNMK GenMark Diagnostics, Inc.
Stock Option (Right to Buy)
M - Exercise -25,000 0 -100.00
2019-08-19 2019-08-15 4 GNMK GenMark Diagnostics, Inc.
Common Stock
F - Taxes -16,870 88,777 -15.97 6.42 -108,305 569,948
2019-08-19 2019-08-15 4 GNMK GenMark Diagnostics, Inc.
Common Stock
F - Taxes -23,365 105,647 -18.11 6.42 -150,003 678,254
2019-08-19 2019-08-15 4 GNMK GenMark Diagnostics, Inc.
Common Stock
M - Exercise 18,050 129,012 16.27 6.00 108,300 774,072
2019-08-19 2019-08-15 4 GNMK GenMark Diagnostics, Inc.
Common Stock
M - Exercise 25,000 110,962 29.08 6.00 150,000 665,772
2019-08-19 2019-08-15 4 GNMK GenMark Diagnostics, Inc.
Common Stock
S - Sale X -2,200 102,112 -2.11 6.51 -14,322 664,749
2019-07-30 2019-07-26 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
A - Award 11,691 11,691
2019-07-30 2019-07-26 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
A - Award 3,916 16,306 31.61
2019-06-18 2019-06-14 4 SIEN Sientra, Inc.
Common Stock (RSUs)
A - Award 19,320 73,085 35.93
2019-06-11 2019-06-07 4 SIEN Sientra, Inc.
Common Stock
P - Purchase 8,696 53,765 19.29 5.75 50,002 309,149
2019-06-07 2019-06-05 4 NVRO NEVRO CORP
Common Stock
P - Purchase 1,675 8,375 25.00 60.00 100,500 502,500
2019-06-04 2019-05-31 4 GNMK GenMark Diagnostics, Inc.
Common Stock
A - Award 19,851 104,312 23.50
2019-05-22 2019-05-20 4 NVRO NEVRO CORP
Common Stock
A - Award 6,049 6,700 929.19
2019-03-21 2019-03-19 4 NVRO NEVRO CORP
Common Stock
A - Award 651 651
2019-03-05 2019-03-01 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
S - Sale X -6,417 12,390 -34.12 32.00 -205,344 396,480
2019-02-20 2019-02-15 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
S - Sale X -3,583 18,807 -16.00 32.01 -114,680 601,948
2019-02-01 2019-01-31 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
M - Exercise X -30,816 0 -100.00
2019-02-01 2019-01-31 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
S - Sale X -30,816 22,390 -57.92 30.07 -926,566 673,216
2019-02-01 2019-01-31 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
M - Exercise X 30,816 53,206 137.63 22.50 693,360 1,197,135
2019-02-01 2019-01-30 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
M - Exercise X -1,907 30,816 -5.83
2019-02-01 2019-01-30 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
S - Sale X -1,907 22,390 -7.85 30.00 -57,210 671,700
2019-02-01 2019-01-30 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
M - Exercise X 1,907 24,297 8.52 22.50 42,908 546,682
2018-11-14 2018-11-13 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
M - Exercise X -4,537 32,723 -12.18
2018-11-14 2018-11-13 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
S - Sale X -4,537 22,390 -16.85 30.02 -136,207 672,177
2018-11-14 2018-11-13 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
M - Exercise X 4,537 26,927 20.26 22.50 102,082 605,858
2018-11-14 2018-11-12 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
M - Exercise X -12,740 37,260 -25.48
2018-11-14 2018-11-12 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
S - Sale X -12,740 22,390 -36.27 30.14 -384,031 674,917
2018-11-14 2018-11-12 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
M - Exercise X 12,740 35,130 56.90 22.50 286,650 790,425
2018-07-26 2018-07-25 4 wMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -626 22,389 -2.72 24.83 -15,544 555,919
2018-07-26 2018-07-24 4 wMGI Wright Medical Group N.V.
Stock Option (right to buy)
A - Award 9,907 9,907
2018-07-26 2018-07-24 4 wMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
A - Award 3,804 23,015 19.80
2018-06-07 2018-06-05 4 SIEN Sientra, Inc.
Common Stock (RSUs)
A - Award 6,116 45,069 15.70 20.44 125,011 921,210
2018-05-29 2018-05-24 4 GNMK GenMark Diagnostics, Inc.
Common Stock
A - Award 18,866 84,461 28.76
2018-05-09 2018-05-07 4 SIEN Sientra, Inc.
Common Stock
P - Purchase 7,407 38,953 23.48 13.50 99,994 525,866
2017-07-26 2017-07-25 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
A - Award 10,275 10,275
2017-07-26 2017-07-25 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
A - Award 3,586 19,211 22.95
2017-07-21 2017-07-19 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -1,428 15,625 -8.37 27.58 -39,384 430,938
2017-06-26 2017-06-22 4 SIEN Sientra, Inc.
Common Stock
A - Award 12,861 31,546 68.83 9.72 125,009 306,627
2017-05-30 2017-05-25 4 GNMK GenMark Diagnostics, Inc.
Common Stock
A - Award 7,832 65,595 13.56
2017-04-28 2017-04-28 4 ZLTQ Zeltiq Aesthetics Inc
Stock Options (Right to Buy)
J - Other -30,000 0 -100.00
2017-04-28 2017-04-28 4 ZLTQ Zeltiq Aesthetics Inc
Stock Options (Right to Buy)
J - Other -10,645 0 -100.00
2017-04-28 2017-04-28 4 ZLTQ Zeltiq Aesthetics Inc
Stock Options (Right to Buy)
J - Other -40,871 0 -100.00
2017-04-28 2017-04-28 4 ZLTQ Zeltiq Aesthetics Inc
Stock Options (Right to Buy)
J - Other -1,391 0 -100.00
2017-04-28 2017-04-28 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other -11,985 0 -100.00
2016-10-17 2016-10-13 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -1,177 17,053 -6.46 23.71 -27,907 404,327
2016-09-19 2016-09-15 4 ZLTQ Zeltiq Aesthetics Inc
Stock Options (Right to Buy)
M - Exercise -7,500 10,645 -41.33
2016-09-19 2016-09-15 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
S - Sale X -7,500 11,985 -38.49 40.08 -300,612 480,378
2016-09-19 2016-09-15 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
M - Exercise 7,500 19,485 62.58 6.34 47,550 123,535
2016-08-10 2016-08-09 4 ZLTQ Zeltiq Aesthetics Inc
Stock Options (Right to Buy)
M - Exercise -11,855 18,145 -39.52
2016-08-10 2016-08-09 4 ZLTQ Zeltiq Aesthetics Inc
Stock Options (Right to Buy)
M - Exercise -5,645 1,391 -80.23
2016-08-10 2016-08-09 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
S - Sale X -7,500 11,985 -38.49 39.00 -292,500 467,415
2016-08-10 2016-08-09 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
S - Sale X -10,000 19,485 -33.92 37.00 -370,000 720,945
2016-08-10 2016-08-09 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
M - Exercise 11,855 29,485 67.24 6.34 75,161 186,935
2016-08-10 2016-08-09 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
M - Exercise 5,645 17,630 47.10 5.06 28,564 89,208
2016-07-21 2016-07-19 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
A - Award 11,765 11,765
2016-07-21 2016-07-19 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
A - Award 4,094 18,230 28.96
2016-06-27 2016-06-23 4 SIEN Sientra, Inc.
Common Stock
A - Award 18,685 18,685 6.69 125,003 125,003
2016-06-23 2016-06-16 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
A - Award 6,199 11,985 107.14 28.23 174,998 338,337
2016-05-31 2016-05-26 4 GNMK GenMark Diagnostics, Inc.
Common Stock
A - Award 9,965 57,763 20.85
2015-11-04 2015-11-03 4 GNMK GenMark Diagnostics, Inc.
Common Stock
P - Purchase 4,500 47,798 10.39 6.71 30,195 320,725
2015-10-15 2015-10-13 4 WMGI Wright Medical Group N.V.
Stock Option (right to buy)
A - Award 11,018 11,018
2015-10-15 2015-10-13 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
A - Award 3,808 14,136 36.87
2015-10-05 2015-10-01 4 WMGI Wright Medical Group N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -423 10,328 -3.93 20.67 -8,743 213,480
2015-08-14 2015-08-12 4 TRNX Tornier N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -493 10,751 -4.38 23.85 -11,758 256,411
2015-08-14 2015-06-26 4 SIEN Sientra, Inc.
Stock Option (right to buy)
A - Award 7,037 16,127 77.41
2015-08-11 2015-08-10 4 TRNX Tornier N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -314 11,244 -2.72 23.78 -7,467 267,382
2015-08-11 2015-08-09 4 TRNX Tornier N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -591 11,558 -4.86 23.82 -14,078 275,312
2015-08-06 2015-08-05 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (Right to Buy)
M - Exercise -2,500 7,036 -26.22
2015-08-06 2015-08-05 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (Right to Buy)
M - Exercise -7,500 0 -100.00
2015-08-06 2015-08-05 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
S - Sale X -2,500 5,786 -30.17 37.02 -92,545 214,186
2015-08-06 2015-08-05 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
S - Sale X -7,500 8,286 -47.51 37.03 -277,760 306,870
2015-08-06 2015-08-05 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
M - Exercise 2,500 15,786 18.82 5.06 12,650 79,877
2015-08-06 2015-08-05 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
M - Exercise 7,500 13,286 129.62 6.03 45,225 80,115
2015-08-03 2015-07-31 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (Right to Buy)
M - Exercise -7,800 7,500 -50.98
2015-08-03 2015-07-31 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
S - Sale X -1,200 5,786 -17.18 35.57 -42,684 205,808
2015-08-03 2015-07-31 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
S - Sale X -6,600 6,986 -48.58 34.72 -229,157 242,560
2015-08-03 2015-07-31 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
M - Exercise 7,800 13,586 134.81 6.03 47,034 81,924
2015-07-27 2015-07-24 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (Right to Buy)
M - Exercise -3,900 15,300 -20.31
2015-07-27 2015-07-24 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
S - Sale X -3,900 5,786 -40.26 33.00 -128,700 190,938
2015-07-27 2015-07-24 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
M - Exercise 3,900 9,686 67.40 6.03 23,517 58,407
2015-07-23 2015-07-22 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
A - Award 790 5,786 15.81
2015-06-29 2015-06-26 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (Right to Buy)
M - Exercise -800 19,200 -4.00
2015-06-29 2015-06-26 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
S - Sale X -800 4,996 -13.80 33.00 -26,400 164,868
2015-06-29 2015-06-26 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
M - Exercise 800 5,796 16.01 6.03 4,824 34,950
2015-06-19 2015-06-17 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
A - Award 4,996 4,996
2015-06-01 2015-05-28 4 GNMK GenMark Diagnostics, Inc.
Common Stock
A - Award 7,604 43,298 21.30
2014-12-17 2014-12-16 4 GNMK GenMark Diagnostics, Inc.
Common Stock
S - Sale X -291 35,694 -0.81 12.40 -3,608 442,606
2014-11-18 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Stock Option (right to buy)
D - Sale to Issuer -8,575 0 -100.00
2014-11-18 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Stock Option (right to buy)
D - Sale to Issuer -11,145 0 -100.00
2014-11-18 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Stock Option (right to buy)
D - Sale to Issuer -2,813 0 -100.00
2014-11-18 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Stock Option (right to buy)
D - Sale to Issuer -1,875 0 -100.00
2014-11-18 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Stock Option (right to buy)
D - Sale to Issuer -1,875 0 -100.00
2014-11-18 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Stock Option (right to buy)
D - Sale to Issuer -6,250 0 -100.00
2014-11-18 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Common Stock
D - Sale to Issuer -5,000 0 -100.00
2014-09-18 2014-09-16 4 GNMK GenMark Diagnostics, Inc.
Common Stock
S - Sale X -262 35,985 -0.72 9.57 -2,507 344,376
2014-09-15 2014-09-11 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (Right to Buy)
M - Exercise -5,000 20,000 -20.00
2014-09-15 2014-09-11 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
S - Sale -100 0 -100.00 26.05 -2,605
2014-09-15 2014-09-11 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
S - Sale X -4,900 100 -98.00 25.49 -124,920 2,549
2014-09-15 2014-09-11 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
M - Exercise 5,000 5,000 6.03 30,150 30,150
2014-09-04 2014-09-02 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (Right to Buy)
M - Exercise -5,000 25,000 -16.67
2014-09-04 2014-09-02 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
S - Sale X -5,000 0 -100.00 23.01 -115,030
2014-09-04 2014-09-02 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
M - Exercise 5,000 5,000 6.03 30,150 30,150
2014-08-13 2014-08-12 4/A TRNX Tornier N.V.
Stock Option (right to buy)
A - Award 6,034 6,034
2014-08-12 2014-08-12 4 TRNX Tornier N.V.
Stock Option (right to buy)
A - Award 6,034 6,034
2014-08-12 2014-08-12 4 TRNX Tornier N.V.
Ordinary Shares, par value EUR 0.03 per share
A - Award 2,728 12,149 28.96
2014-08-12 2014-08-11 4 TRNX Tornier N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -873 9,421 -8.48 21.73 -18,970 204,718
2014-07-31 2014-07-30 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (Right to Buy)
M - Exercise -5,000 30,000 -14.29
2014-07-31 2014-07-30 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
S - Sale X -5,000 0 -100.00 21.08 -105,388
2014-07-31 2014-07-30 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
M - Exercise 5,000 5,000 6.03 30,150 30,150
2014-06-13 2014-06-11 4 GNMK GenMark Diagnostics, Inc.
Common Stock
S - Sale X -272 36,247 -0.74 11.64 -3,166 421,915
2014-06-03 2014-05-30 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (Right to Buy)
A - Award 30,000 30,000
2014-06-02 2014-05-29 4 GNMK GenMark Diagnostics, Inc.
Common Stock
A - Award 6,345 36,519 21.03
2014-05-30 2014-05-29 4 GNMK GenMark Diagnostics, Inc.
Common Stock
S - Sale X -1,603 30,174 -5.04 10.98 -17,593 331,160
2014-05-23 2014-05-21 4 DRTX Durata Therapeutics, Inc.
Stock Option (right to buy)
A - Award 8,575 32,533 35.79
2014-05-14 2014-05-12 4 TRNX Tornier N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -228 10,294 -2.17 20.92 -4,770 215,350
2014-03-05 2014-03-04 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (Right to Buy)
M - Exercise -15,000 35,000 -30.00
2014-03-05 2014-03-04 4 ZLTQ Zeltiq Aesthetics Inc
Common stock
S - Sale X -15,000 0 -100.00 19.31 -289,674
2014-03-05 2014-03-04 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
M - Exercise X 15,000 15,000 6.03 90,450 90,450
2013-08-13 2013-08-10 4 TRNX Tornier N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -222 10,522 -2.07 19.45 -4,318 204,653
2013-08-13 2013-08-09 4 TRNX Tornier N.V.
Stock Option (right to buy)
A - Award 7,538 7,538
2013-08-13 2013-08-09 4 TRNX Tornier N.V.
Ordinary Shares, par value EUR 0.03 per share
A - Award 3,490 10,744 48.11
2013-06-20 2013-06-19 4 ZLTQ Zeltiq Aesthetics Inc
Stock Options (Right to Buy)
A - Award 30,000 30,000
2013-05-23 2013-05-22 4 GNMK GenMark Diagnostics, Inc.
Common Stock
A - Award 7,232 31,777 29.46
2013-05-20 2013-05-16 4 DRTX Durata Therapeutics, Inc.
Stock Option (right to buy)
A - Award 11,145 23,958 86.98
2013-05-20 2013-05-16 4 DRTX Durata Therapeutics, Inc.
Stock Option (right to buy)
A - Award 1,875 12,813 17.14
2013-05-20 2013-05-16 4 DRTX Durata Therapeutics, Inc.
Stock Option (right to buy)
A - Award 2,813 10,938 34.62
2013-05-14 2013-05-12 4 TRNX Tornier N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -248 7,254 -3.31 16.66 -4,132 120,852
2012-09-18 2012-09-14 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (Right to Buy)
A - Award 50,000 50,000
2012-08-14 2012-08-10 4 TRNX Tornier N.V.
Stock Option (right to buy)
A - Award 6,448 6,448
2012-08-14 2012-08-10 4 TRNX Tornier N.V.
Ordinary Shares, par value EUR 0.03 per share
A - Award 2,947 7,502 64.70
2012-07-03 2012-06-30 4 TRNX Tornier N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -29 4,555 -0.63 22.42 -650 102,123
2012-06-28 2012-06-26 4 GNMK GenMark Diagnostics, Inc.
Common Stock
P - Purchase 11,905 24,545 94.19 4.20 50,001 103,089
2012-06-19 2012-06-14 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (Right to Buy)
A - Award 9,536 9,536
2012-06-08 2012-06-06 4 GNMK GenMark Diagnostics, Inc.
Common Stock
A - Award 12,640 12,640
2012-05-15 2012-05-12 4 TRNX Tornier N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -268 4,584 -5.52 20.98 -5,623 96,172
2012-04-03 2012-03-31 4 TRNX Tornier N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -14 4,852 -0.29 25.70 -360 124,696
2012-01-05 2012-01-03 4 GNMK GenMark Diagnostics, Inc.
Stock Option (Right to Buy)
A - Award 13,426 13,426
2012-01-03 2011-12-31 4 TRNX Tornier N.V.
Ordinary Shares, par value EUR 0.03 per share
F - Taxes -6 4,866 -0.12 18.00 -108 87,588
2006-03-16 2006-03-14 4 NUVA NUVASIVE INC
Stock Option (Right to Buy)
M - Exercise -6,667 110,000 -5.71
2006-03-16 2006-03-14 4 NUVA NUVASIVE INC
Common Stock
S - Sale X -2,500 0 -100.00 20.00 -50,000
2006-03-16 2006-03-14 4 NUVA NUVASIVE INC
Common Stock
S - Sale X -4,167 2,500 -62.50 19.79 -82,484 49,486
2006-03-16 2006-03-14 4 NUVA NUVASIVE INC
Common Stock
M - Exercise 6,667 6,667 0.63 4,200 4,200
2006-03-16 2006-03-14 4 NUVA NUVASIVE INC
Common Stock
S - Sale X -833 0 -100.00 19.79 -16,489
2004-12-21 2004-12-17 4 NUVA NUVASIVE INC
Stock Option (Right to Buy)
A - Award 25,000 25,000 9.50 237,500 237,500
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)